Thyroid transcription factor by IHC

Alphabetical Test listing

Thyroid transcription factor by IHC-12376 - Technical only;12379 - Technical & interpretation

  
Thyroid transcription factor by IHC
  
12376 - Technical only
12379 - Technical & interpretation
  
LAB12376
LAB12379
  
TTF-1
  
  • All IHC stains will include a positive control tissue
  
  • TTF-1 is present in normal thyroid and neoplastic thyroid tumors such as papillary carcinoma
  • TTF-1 is present in the majority of pulmonary adenocarcinomas (73-76%) and pulmonary small cell carcinomas (83%)
  • A smaller proportion of large cell undifferentiated lung carcinomas (26%) stain for TTF-1.
  • Squamous cell carcinomas of the lung do not stain for TTF-1
  • Malignant mesotheliomas are negative for TTF-1
  • Cytoplasmic staining for TTF-1 can be useful in identifying hepatocellular carcinoma
  • Papillary nasopharyngeal carcinomas have been reported to stain for this marker
  • A small proportion of breast cancers will stain for this marker (2.4% of 546 primary breast cancers in one study)
  • Small cell carcinomas of the prostate are positive for TTF-1
  • Colorectal adenocarcinoma (including metastatic to the lung) can show diffuse, moderate to strong TTF-1 positivity. It is estimated up to 3% of colorectal adenocarcinomas will be TTF-1 positive with the TTF-1 clone we use (Dako clone 8G7G3/1). While the majority of these cases will demonstrate weak TTF-1 positivity, diffuse, strong positivity can occur
  • Other tumors have been rarely reported to be TTF-1 positive (nuclear), and include cholangiocarcinoma, endometrial, ovarian, gastric/esophageal, cervical, pancreatic ductal, urothelial, hepatocellular, adenoid cystic, other salivary gland carcinomas, and adrenal cortical carcinoma. Typically, these tumors will show expression in a small fraction of tumor cells.
  
Tissue
  

Submit a formalin-fixed, paraffin embedded tissue block

.

  

Formalin-fixed, paraffin embedded (FFPE) tissue block

  

FFPE tissue section mounted on a charged, unstained slide

  

Ambient (preferred)

  
AHL - Immunohistochemistry
  
Mo - Fr
  
1 - 2 days
  

Immunohistochemical staining and microscopic examination

  

If requested, an interpretive report will be provided

  

Specifications

  • Reacts with a transcription factor that is expressed selectively in the thyroid, lung, and diencephalon
  • In the lung, TTF-1 is present in Type II Cells and Clara Cells and is important in the activation of pulmonary-specific differentiation genes
  • In thyroid, TTF-1 is present in follicular epithelial cells
  • TTF-1 is expressed early in the embryogenesis of thyroidal and respiratory epithelium, arising from endoderm of the foregut
  • TTF-1 expression has also been found in some endometrial and endocervical carcinomas 8
  • Cytoplasmic staining for TTF-1 with this clone can be seen in hepatocellular carcinoma

 Staining patterns

  • Nuclear staining in lung, thyroid, and papillary nasopharyngeal carcinoma
  • Cytoplasmic staining in hepatocellular carcinoma

References

  1. Holzinger A, et. Al. Monoclonal Antibody to Thyroid Transcription Factor – 1: Production, Characterization, and Usefulness in Tumor Diagnosis. Hybridoma, Vol. 15 (1): 49, 1996.
  2. Harlamert HA et al. Distinguishing Primary Lung Adenocarcinomas from Metastatic Breast Adenocarcinomas in Cytology Specimens using TTF-1 and Cytokeratins 7 and 20. Mod Path, 10(1): A185, 1997.
  3. Anderson SS, et al. Thyroid Transcription Factor -1 (TTF-1) is a More Sensitive Lung Carcinoma Marker than Surfactant. ApoA1. Lab Invest, 78(1): 171A (1001), 1998.
  4. Bohinski RJ, et al. Determination of Lung as the Primary Site of Cerebral Metastatic Adenocarcinomas using Monoclonal Antibody to Thyroid Transcription Factor -1. J Neuro-Oncology, 1998.
  5. Bejarano P.A., et al. Surfactant Proteins and Thyroid Transcription Factor -1 in Pulmonary and Breast Carcinomas. Mod Path, 9(4): 445, 1996.
  6. Khoor A, et al. Utility of Surfactant Protein B Precursor and Thyroid Transcription Factor – 1 in Differentiating Adenocarcinomas of the Lung from Malignant Mesothelioma. In press.
  7. Dilorecto C, et al. TTF-1 Protein Expression in Pleural Malignant Mesotheliomas and Adenocarcinomas of the Lung. Cancer, 124(1): 73-78, 1998.
  8. Siami K et al: Transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J Surg Pathol 2007, 31 (11) 1759-1763.
  9. Pineda-Daboin K et al: Nasopharyngeal adenocarcinomas: a clinicopathologic study of 44 cases including immunohistochemical features of 18 papillary phenotypes. Annal Diag Pathology 9(2005):189-192.
  10. Lei J et al: Cytoplasmic Staining of TTF-1 in the Differential Diagnosis of Hepatocellular Carcinoma vs Cholangiocarcinoma and Metastatic Carcinoma of the Liver. Am J Clin Pathol 2006;125:519-525.
  11. Goldstein RJ , Gown AM, Schnitt SJ: Thyroid transcription factor-1 expression in breast carcinomas. Am J Surg Pathol 2010 Dec;34(12):1881-5.
  12. Wang W, Epstein JI. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol. 2008 Jan;32(1):65-71. PubMed PMID: 18162772.
  13. Conner JR, Hornick JL: Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry. Adv Anat Pathol 2015;22:149-167.
  
88342 - 1st stain
88341 - each additional stain
  
No
  
10/17/2018
  
10/17/2018
  
10/02/2020